This inventor holds 1 USPTO granted patent. Top assignee: Technology Unlimited, Inc.. Active years: 1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988
Title: The Innovative Mind of Walter B. Geho
Introduction
Walter B. Geho is a notable inventor based in Wooster, Ohio. He has made significant contributions to the field of diabetes management through his innovative research and patent. His work focuses on the complex interactions between insulin and serotonin in regulating glucose levels in the liver.
Latest Patents
Walter B. Geho holds a patent for his groundbreaking discovery titled "Diabetes control by serotonin." This patent highlights the understanding that insulin alone does not fully control liver function regarding glucose uptake, release, and synthesis. Geho's research reveals that serotonin, released in the portal vein in response to glucose presence in the gut, plays a crucial role in this process. In the absence of portal serotonin, the liver fails to take up and store glucose, leading to increased glucose synthesis. This insight is particularly relevant for adult-onset diabetics, who often have sufficient natural insulin but may experience serotonin deficiencies that hinder glucose control.
Career Highlights
Walter B. Geho has dedicated his career to advancing diabetes treatment through innovative research. He is currently associated with Technology Unlimited, Inc., where he continues to explore the implications of his findings on diabetes management. His work has the potential to transform how diabetes is treated, offering new avenues for therapy that address the underlying hormonal interactions involved in glucose regulation.
Collaborations
[Section skipped due to space constraints.]
Conclusion
Walter B. Geho's contributions to diabetes research exemplify the importance of innovation in medical science. His patent on serotonin's role in glucose control opens new possibilities for improving diabetes management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile